VKH
AXN

Virtu KCG Holdings’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Virtu KCG Holdings’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,012
Closed -$6K – 3857
2017
Q1 		$6K Sell
16,012
-7,323
-31% -$3.15K ﹤0.01% 3042
2016
Q4 		$7K Sell
23,335
-8,984
-28% -$3.72K ﹤0.01% 3317
2016
Q3 		$18K Buy
+32,319
New +$21.7K ﹤0.01% 2929
2016
Q2 		– Sell
-16,819
Closed -$11K – 3570
2016
Q1 		$11K Sell
16,819
-101,569
-86% -$75K ﹤0.01% 2650
2015
Q4 		$79K Buy
118,388
+39,328
+50% +$49.4K ﹤0.01% 3060
2015
Q3 		$117K Buy
+79,060
New +$125K ﹤0.01% 2785
2015
Q2 		– Sell
-46,541
Closed -$79K – 4009
2015
Q1 		$79K Buy
+46,541
New +$43.4K ﹤0.01% 2708
2014
Q3 		– Sell
-11,647
Closed -$4K – 4343
2014
Q2 		$4K Sell
11,647
-906
-7% -$353 ﹤0.01% 3568
2014
Q1 		$5K Buy
+12,553
New +$4.48K ﹤0.01% 3468

Other funds holding AXN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Virtu KCG Holdings's AXN Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q2 2017, closing a stake of 16,012 shares — an estimated $6K sold.

Virtu KCG Holdings first reported a position in AXN in Q1 2014 and held it in 9 quarters. The position peaked at $117K in Q3 2015. 7 funds tracked by Wall St. Rank hold AXN as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 16,012 Aoxing Pharmaceutical Company Inc. shares in Q2 2017, an estimated $6K.
  • Virtu KCG Holdings first reported a position in Aoxing Pharmaceutical Company Inc. in Q1 2014 and held it in 9 quarters.
  • Virtu KCG Holdings's Aoxing Pharmaceutical Company Inc. position peaked at $117K in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.